Fig. 1.
Fig. 1. Expression of uPAR on monocytes in AMI. / (A) Representative flow cytometric histograms showing uPAR expression (mAb R4) in one patient with AMI and one with CSA. The far left peak represents the nonspecific control mAb. (B) Flow cytometric analysis of healthy controls (CON) and patients with CSA or AMI (n = 20 in each group). Values shown are the mean immunofluorescence ± SD. (C) Relative uPAR mRNA expression in MNCs isolated from 3 patients with CSA or AMI. Values shown are the means; error bars indicate range in relation to healthy controls (dotted line). (D) Expression of uPAR mRNA in monocytic MonoMac6 cells incubated with pooled plasma from patients with CSA or AMI. One experiment representative of 3 is shown.

Expression of uPAR on monocytes in AMI.

(A) Representative flow cytometric histograms showing uPAR expression (mAb R4) in one patient with AMI and one with CSA. The far left peak represents the nonspecific control mAb. (B) Flow cytometric analysis of healthy controls (CON) and patients with CSA or AMI (n = 20 in each group). Values shown are the mean immunofluorescence ± SD. (C) Relative uPAR mRNA expression in MNCs isolated from 3 patients with CSA or AMI. Values shown are the means; error bars indicate range in relation to healthy controls (dotted line). (D) Expression of uPAR mRNA in monocytic MonoMac6 cells incubated with pooled plasma from patients with CSA or AMI. One experiment representative of 3 is shown.

Close Modal

or Create an Account

Close Modal
Close Modal